11 Apr 2019

hVIVO is Gold Sponsor and presenter at World Vaccine Congress, Washington DC, USA April 2019

Share this:

WVC 2017, 14-17 April 2019, Renaissance Washington DC Downtown Hotel, Washington DC, USA hVIVO is proud to once again be a Gold Sponsor of the World Vaccine Congress 2019, a significant USA vaccine event. At the World Vaccine Congress in April 2019 more than 300 elite speakers and 1,500 attendees will participate in unparalleled learning opportunities in vaccine development. hVIVO's joint venture, Imutex Limited, will present during the second day of the conference, April 16th at 14:40 local time.

'FLU-v, a broad spectrum influenza vaccine: Efficacy and Immunogenicity' Dr Olga Pleguezuelos, CSO and Project Manager, Imutex, SEEK and hVIVO.

At the event will be Rich Niemi and Reid Tripp from our Business Development team. hVIVO will have a display stand in the exhibit area adjacent to the conference facilities on stand number 306. If you would like to make contact with either Nicolas or one of his business development colleagues before or during the event, please use the enquiry form below.

Other recent posts

Blog

Unlock Your RSV Research: How hVIVO’s RSV Strains & Human Challenge Models can Revolutionise your RSV Research

Virus portfolio: Respiratory Syncytial Virus RSV was first discovered in 1956. It was initially identified in chimpanzees by Dr. Robert Chanock and his colleagues while working at the National Institutes...

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Contact hVIVO